IL-23-induced skin inflammation was virtually eliminated in DT-treated CD11c-DTR mice, Ccr6−/− mice and mice transplanted with a mixture of Ccr6−/− and CD11c-DTR bone marrow and treated with DT. Here, IL23A is linked to dermatitis.